Virtu Financial’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,791
| Closed | -$8K | – | 2209 |
|
|
2024
Q4 | $8K | Buy |
32,791
+13,162
| +67% | +$3.21K | ﹤0.01% | 1410 |
|
|
2024
Q3 | $42K | Buy |
+19,629
| New | +$42K | ﹤0.01% | 1044 |
|
|
2024
Q2 | – | Sell |
-12,030
| Closed | -$64K | – | 1999 |
|
|
2024
Q1 | $64K | Buy |
+12,030
| New | +$64K | ﹤0.01% | 985 |
|
|
2023
Q1 | – | Sell |
-12,428
| Closed | -$45K | – | 2211 |
|
|
2022
Q4 | $45K | Buy |
+12,428
| New | +$45K | 0.01% | 1102 |
|
|
2022
Q3 | – | Sell |
-1,183
| Closed | -$11K | – | 2340 |
|
|
2022
Q2 | $11K | Sell |
1,183
-69
| -6% | -$642 | ﹤0.01% | 1421 |
|
|
2022
Q1 | $15K | Buy |
+1,252
| New | +$15K | ﹤0.01% | 1338 |
|
|
2021
Q4 | – | Sell |
-2,094
| Closed | -$94K | – | 2270 |
|
|
2021
Q3 | $94K | Buy |
+2,094
| New | +$94K | 0.01% | 1161 |
|
|
2021
Q2 | – | Sell |
-3,399
| Closed | -$254K | – | 2168 |
|
|
2021
Q1 | $254K | Buy |
+3,399
| New | +$254K | 0.02% | 914 |
|
|
2018
Q1 | – | Sell |
-1,966
| Closed | -$191K | – | 2735 |
|
|
2017
Q4 | $191K | Buy |
+1,966
| New | +$191K | 0.01% | 1704 |
|